BJCT-BIOJECT-needle less injection product Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: minks who wrote (458)	8/21/2005 7:49:59 AM
From: Gary105	Read Replies (1) of 534

Minks, Growing revenues and diminishing loss as a result of animal vaccine. Also Roche/Trimeris filed for FDA approval of Bioject injector for Fuzeon HIV drug. Breakout above 200 D MA and unfilled gap in the upper single digits. All imo,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next